Ervin R. Spitzmiller

457 total citations
17 papers, 333 citations indexed

About

Ervin R. Spitzmiller is a scholar working on Organic Chemistry, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Ervin R. Spitzmiller has authored 17 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Organic Chemistry, 11 papers in Molecular Biology and 2 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Ervin R. Spitzmiller's work include Chemical Synthesis and Analysis (5 papers), Synthesis and Reactivity of Heterocycles (5 papers) and Synthesis and Biological Evaluation (5 papers). Ervin R. Spitzmiller is often cited by papers focused on Chemical Synthesis and Analysis (5 papers), Synthesis and Reactivity of Heterocycles (5 papers) and Synthesis and Biological Evaluation (5 papers). Ervin R. Spitzmiller collaborates with scholars based in United States, Malaysia and Germany. Ervin R. Spitzmiller's co-authors include John Krapcho, Chester F. Turk, Harry L. Yale, Edward W. Petrillo, J.R. Powell, Jack M. DeForrest, David W. Cushman, Donald S. Karanewsky, Mark E. Duggan and George C. Rovnyak and has published in prestigious journals such as Journal of Medicinal Chemistry, Tetrahedron Letters and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Ervin R. Spitzmiller

16 papers receiving 302 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ervin R. Spitzmiller United States 9 242 140 32 31 21 17 333
James S. Kaltenbronn United States 10 176 0.7× 185 1.3× 15 0.5× 31 1.0× 17 0.8× 18 319
Tamara Dejneka United States 9 145 0.6× 114 0.8× 28 0.9× 29 0.9× 6 0.3× 13 264
John J. Fitt United States 12 294 1.2× 110 0.8× 42 1.3× 15 0.5× 24 1.1× 17 379
K. ISHIZUMI Japan 8 184 0.8× 116 0.8× 12 0.4× 52 1.7× 21 1.0× 23 294
Ho‐Shen Lin United States 9 214 0.9× 116 0.8× 28 0.9× 14 0.5× 13 0.6× 15 330
Paivi J. Kukkola United States 12 280 1.2× 140 1.0× 34 1.1× 14 0.5× 26 1.2× 17 400
Francis J. McEvoy United States 13 357 1.5× 182 1.3× 19 0.6× 16 0.5× 19 0.9× 31 428
Saroop S. Matharu 9 296 1.2× 130 0.9× 14 0.4× 15 0.5× 20 1.0× 11 382
Ettore Lazzari Italy 9 179 0.7× 182 1.3× 9 0.3× 35 1.1× 26 1.2× 13 329
Suzanne A. Lebold United States 10 267 1.1× 200 1.4× 22 0.7× 9 0.3× 32 1.5× 13 360

Countries citing papers authored by Ervin R. Spitzmiller

Since Specialization
Citations

This map shows the geographic impact of Ervin R. Spitzmiller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ervin R. Spitzmiller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ervin R. Spitzmiller more than expected).

Fields of papers citing papers by Ervin R. Spitzmiller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ervin R. Spitzmiller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ervin R. Spitzmiller. The network helps show where Ervin R. Spitzmiller may publish in the future.

Co-authorship network of co-authors of Ervin R. Spitzmiller

This figure shows the co-authorship network connecting the top 25 collaborators of Ervin R. Spitzmiller. A scholar is included among the top collaborators of Ervin R. Spitzmiller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ervin R. Spitzmiller. Ervin R. Spitzmiller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Lloyd, John, Denis E. Ryono, J. Eileen Bird, et al.. (1994). Quinoline-4-carboxylic acids as angiotensin II receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 4(1). 195–200. 10 indexed citations
2.
Poss, Michael A., Zhengxiang Gu, Denis E. Ryono, et al.. (1994). 1,4-substituted indoles: a potent and selective class of angiostensin II receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 4(1). 145–150. 10 indexed citations
3.
Ryono, Denis E., John Lloyd, Michael A. Poss, et al.. (1994). Orally active prodrugs of quinoline-4-carboxylic acid angiotensin II receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 4(1). 201–206. 22 indexed citations
4.
Krapcho, John, Chester F. Turk, David W. Cushman, et al.. (1988). Angiotensin-converting enzyme inhibitors. Mercaptan, carboxyalkyl dipeptide, and phosphinic acid inhibitors incorporating 4-substituted prolines. Journal of Medicinal Chemistry. 31(6). 1148–1160. 121 indexed citations
5.
Petrillo, Edward W. & Ervin R. Spitzmiller. (1979). Synthesis of 2-phosphonopyrrolidine and its substitution for proline in an inhibitor of angiotensin-converting enzyme. Tetrahedron Letters. 20(51). 4929–4930. 39 indexed citations
6.
Yale, Harry L. & Ervin R. Spitzmiller. (1978). 3,5‐Disubstituted‐1,2,4‐oxadiazoles and 4,5‐dihydro‐3,5‐disubstituted‐1,2,4‐oxadiazoles. Journal of Heterocyclic Chemistry. 15(8). 1373–1378. 12 indexed citations
7.
Yale, Harry L. & Ervin R. Spitzmiller. (1977). The reaction of 2‐acetoacetamidopyridines with phosgene. A route to novel 3‐Acetyl‐2‐chloro‐4H‐pyrido[ 1,2‐a] pyrimidin‐4‐ones. Journal of Heterocyclic Chemistry. 14(2). 241–244. 2 indexed citations
8.
Yale, Harry L. & Ervin R. Spitzmiller. (1977). 2‐Pyridylenamines via transenamination. Journal of Heterocyclic Chemistry. 14(8). 1419–1421. 2 indexed citations
9.
Yale, Harry L. & Ervin R. Spitzmiller. (1977). 6‐ And 7‐Substituted 4H‐Pyrido[1,2‐a] pyrimidin‐4‐ones. Synthesis via the Acid‐catalyzed Isomerization of 2‐(Acetoacetamido)pyridines. Journal of Heterocyclic Chemistry. 14(4). 637–646. 4 indexed citations
10.
Yale, Harry L. & Ervin R. Spitzmiller. (1976). The reaction of aromatic aldehydes with methyl‐substituted 4H‐pyrido [1,2‐α] pyrimidin‐4‐ones. Journal of Heterocyclic Chemistry. 13(4). 869–871.
11.
Yale, Harry L. & Ervin R. Spitzmiller. (1976). Tetrahydro‐ and octahydropyrido[1,2‐a]pyrimidin‐4‐ones. Journal of Heterocyclic Chemistry. 13(4). 797–805. 8 indexed citations
12.
Yale, Harry L. & Ervin R. Spitzmiller. (1976). 5,12‐Diacylated‐5,6,11,12‐tetrahydrodibenzo[b,f][1,4]‐diazocines and related compounds. Journal of Heterocyclic Chemistry. 13(3). 443–448. 2 indexed citations
13.
Yale, Harry L. & Ervin R. Spitzmiller. (1972). Novel polycyclic heterocycles. IX. Dibenz[b,f] [1,4]oxazocin‐11 (12H)one, 6,11‐dihydro‐12H‐dibenz[b,f] [1,4]oxazocine, and their derivatives. Journal of Heterocyclic Chemistry. 9(4). 911–918. 6 indexed citations
14.
Yale, Harry L., et al.. (1972). Novel polycyclic heterocycles. VIII. 6,11‐dihydro‐12H‐dibenzo[b,f] [1,4]thiazocines and their derivatives. Journal of Heterocyclic Chemistry. 9(4). 899–909. 14 indexed citations
15.
Krapcho, John, Ervin R. Spitzmiller, Chester F. Turk, & Josef Fried. (1964). Serotonin Inhibitors. II.1 2'-(3-Dimethylaminopropylthio)cinnamanilide and Related Compounds. Journal of Medicinal Chemistry. 7(3). 376–377. 4 indexed citations
16.
Krapcho, John, Ervin R. Spitzmiller, & Chester F. Turk. (1963). Substituted 2,3-Dihydro-1,5-benzothiazepin-4(5H)-ones and 3,4-Dihydro-2-phenyl-(2H)-1,6-benzothiazocin-5(6H)-ones. Journal of Medicinal Chemistry. 6(5). 544–546. 66 indexed citations
17.
Krapcho, John, Bernard Rubin, Ervin R. Spitzmiller, et al.. (1963). 2'-(3-Dimethylaminopropylthio)cinnamanilide and Related Compounds: A New Class of Potent and Relatively Specific Serotonin Inhibitors. Journal of Medicinal Chemistry. 6(2). 219–219. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James S. Kaltenbronn Breakdown of academic impact, for papers by Tamara Dejneka Breakdown of academic impact, for papers by John J. Fitt Breakdown of academic impact, for papers by K. ISHIZUMI Breakdown of academic impact, for papers by Ho‐Shen Lin Breakdown of academic impact, for papers by Paivi J. Kukkola Breakdown of academic impact, for papers by Francis J. McEvoy Breakdown of academic impact, for papers by Saroop S. Matharu Breakdown of academic impact, for papers by Ettore Lazzari Breakdown of academic impact, for papers by Suzanne A. Lebold
Rankless by CCL
2026